Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Studies on inhibition mechanism of autoxidation by tannins and flavonoids. III. Inhibition mechanism of tannins isolated from medicinal plants and related compounds on autoxidation of methyl linoleate].
Fujita Y, Komagoe K, Niwa Y, Uehara I, Hara R, Mori H, Okuda T, Yoshida T. Fujita Y, et al. Among authors: hara r. Yakugaku Zasshi. 1988 Jun;108(6):528-37. doi: 10.1248/yakushi1947.108.6_528. Yakugaku Zasshi. 1988. PMID: 3249297 Japanese. No abstract available.
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.
Watanabe R, Ebina K, Gon T, Okano T, Murata K, Murakami K, Maeda Y, Jinno S, Shirasugi I, Son Y, Amuro H, Katayama M, Hara R, Hata K, Yoshikawa A, Yamamoto W, Tachibana S, Hayashi S, Etani Y, Katsushima M, Fukumoto K, Yamada S, Hashimoto M. Watanabe R, et al. Among authors: hara r. Rheumatology (Oxford). 2024 May 9:keae265. doi: 10.1093/rheumatology/keae265. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38724245
A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer.
Nakamura K, Nihei K, Saito Y, Shikama N, Noda SE, Hara R, Imagumbai T, Mizowaki T, Akiba T, Kunieda E, Someya M, Ohga S, Kawamori J, Kozuka T, Ota Y, Inaba K, Kodaira T, Itoh Y, Funakoshi K, Kagami Y. Nakamura K, et al. Among authors: hara r. Int J Clin Oncol. 2024 Jun;29(6):847-852. doi: 10.1007/s10147-024-02517-z. Epub 2024 Apr 17. Int J Clin Oncol. 2024. PMID: 38630382 Clinical Trial.
Erratum: Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4' -BNA/LNA with 9-(aminoethoxy)phenoxazine.
Matsubayashi T, Yoshioka K, Lei Mon SS, Katsuyama M, Jia C, Yamaguchi T, Hara RI, Nagata T, Nakagawa O, Obika S, Yokota T. Matsubayashi T, et al. Among authors: hara ri. Mol Ther Nucleic Acids. 2024 Apr 2;35(2):102182. doi: 10.1016/j.omtn.2024.102182. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38590918 Free PMC article.
Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.
Yoshimura H, Takeda Y, Shirai Y, Yamamoto M, Nakatsubo D, Amiya S, Enomoto T, Hara R, Adachi Y, Edahiro R, Yaga M, Masuhiro K, Koba T, Itoh-Takahashi M, Nakayama M, Takata S, Hosono Y, Obata S, Nishide M, Hata A, Yanagawa M, Namba S, Iwata M, Hamano M, Hirata H, Koyama S, Iwahori K, Nagatomo I, Suga Y, Miyake K, Shiroyama T, Fukushima K, Futami S, Naito Y, Kawasaki T, Mizuguchi K, Kawashima Y, Yamanishi Y, Adachi J, Nogami-Itoh M, Ueki S, Kumanogoh A. Yoshimura H, et al. Among authors: hara r. J Allergy Clin Immunol. 2024 May;153(5):1268-1281. doi: 10.1016/j.jaci.2023.12.030. Epub 2024 Mar 29. J Allergy Clin Immunol. 2024. PMID: 38551536 Free article.
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).
Asai S, Suzuki M, Hara R, Hirano Y, Nagamine S, Kaneko T, Suto T, Okano T, Yoshioka Y, Hirao M, Wakabayashi H, Fujibayashi T, Watanabe T, Takakubo Y, Ishikawa H, Nasu Y, Takemoto T, Kato T, Torikai E, Koyama K, Takagi H, Fujiwara T, Sobue Y, Ohashi Y, Nishiume T, Terabe K, Kojima M, Kojima T, Imagama S. Asai S, et al. Among authors: hara r. Mod Rheumatol. 2024 Mar 6:roae027. doi: 10.1093/mr/roae027. Online ahead of print. Mod Rheumatol. 2024. PMID: 38491996
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.
Shirasugi I, Onishi A, Nishimura K, Yamamoto W, Murakami K, Onizawa H, Maeda Y, Ebina K, Son Y, Amuro H, Katayama M, Hara R, Nagai K, Hiramatsu Y, Hashimoto M, Okano T, Maeda T, Hayashi S, Sendo S, Jinno S, Yamamoto Y, Yamada H, Ueda Y, Saegusa J. Shirasugi I, et al. Among authors: hara r. Int J Rheum Dis. 2024 Mar;27(3):e15097. doi: 10.1111/1756-185X.15097. Int J Rheum Dis. 2024. PMID: 38439176
435 results